ArticleRSC advances2020

Discovery of lixisenatide analogues as long-acting hypoglycemic agents using novel peptide half-life extension technology based on mycophenolic acid.

Chunli Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.